Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Phase I clinical study of the recombinant oncotoxin TP40 in superficial bladder cancer.

Goldberg MR, Heimbrook DC, Russo P, Sarosdy MF, Greenberg RE, Giantonio BJ, Linehan WM, Walther M, Fisher HA, Messing E, et al.

Clin Cancer Res. 1995 Jan;1(1):57-61.

2.

Diagnosis and management of superficial bladder cancer.

Amling CL.

Curr Probl Cancer. 2001 Jul-Aug;25(4):219-78. Review.

PMID:
11514784
3.

An overview of the treatment of superficial bladder cancer. Intravesical chemotherapy.

Duque JL, Loughlin KR.

Urol Clin North Am. 2000 Feb;27(1):125-35, x. Review.

PMID:
10696251
4.

[Management of Ta, T1, and in situ bladder carcinoma: what is new?].

Irani J.

Prog Urol. 2008 May;18 Suppl 5:S94-8. doi: 10.1016/S1166-7087(08)72484-9. Review. French.

PMID:
18585634
5.

Current use and questions concerning intravesical bladder cancer group for superficial bladder cancer.

Dalbagni G, Herr HW.

Urol Clin North Am. 2000 Feb;27(1):137-46,. Review.

PMID:
10696252
6.

The limits of bacillus Calmette-Guerin for carcinoma in situ of the bladder.

Kim JC, Steinberg GD.

J Urol. 2001 Mar;165(3):745-56. Review.

PMID:
11176460

Supplemental Content

Support Center